Introduction: Holmium laser enucleation of the prostate (HoLEP) is becoming the new standard procedure for treating benign prostatic hyperplasia (BPH), a common condition in aging men. Most studies have focused on proving its efficacy in treating large prostates. In this study, we compared its efficacy in treating small (< 80 mL) and large (> 80 mL) prostates. Methods: This prospective study included 119 patients with BPH who underwent HoLEP by the same surgeon between June 2015 and December 2017. They were divided into 2 groups according to their prostate volumes (≤80 mL: Group 1; > 80 mL: Group 2). Various pre- and postoperative parameters were compared within and between the groups. Results: International Prostate Symptom Score (IPSS), postvoid residual (PVR) volume, and voiding time (VT) significantly decreased, and the peak urinary flow rate (Qmax), average urinary flow rate (Qave), and quality of life (QoL) score significantly increased postoperatively in both groups. The postoperative changes in IPSS, QoL score, Qmax, Qave, VT, PVR volume, and hemoglobin levels were not significantly different between the groups. In addition, no significant difference was observed in postoperative complications between the groups. Conclusions: Our results indicate that HoLEP is an effective procedure for treating both small and large prostates.

Keywords:
Holmium laser enucleation of the prostate, Prostate, Benign prostate hyperplasia, Laser
1.
Sivarajan G, Borofsky MS, Shah O, Lingeman JE, Lepor H. The Role of Minimally Invasive Surgical Techniques in the Management of Large-gland Benign Prostatic Hypertrophy.
Rev Urol
. 2015; 17(3): 140–9.
2.
McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia.
J Urol
. 2011 May; 185(5): 1793–803.
3.
Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size-independent new “gold standard”.
Urology
. 2005 Nov; 66(5 Suppl): 108–13.
4.
Michalak J, Tzou D, Funk J. HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century.
Am J Clin Exp Urol
. 2015 Apr; 3(1): 36–42.
5.
Vincent MW, Gilling PJ. HoLEP has come of age.
World J Urol
. 2015 Apr; 33(4): 487–93.
6.
Elshal AM, Mekkawy R, Laymon M, Barakat TS, Elsaadany MM, El-Assmy A, et al. Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country?
World J Urol
. 2016 Mar; 34(3): 399–405.
7.
Park S, Kwon T, Park S, Moon KH. Efficacy of Holmium Laser Enucleation of the Prostate in Patients with a Small Prostate (≤30 mL).
World J Mens Health
. 2017 Dec; 35(3): 163–9.
8.
Lee MH, Yang HJ, Kim DS, Lee CH, Jeon YS. Holmium laser enucleation of the prostate is effective in the treatment of symptomatic benign prostatic hyperplasia of any size including a small prostate.
Korean J Urol
. 2014 Nov; 55(11): 737–41.
9.
Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR. Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience.
J Endourol
. 1995 Apr; 9(2): 151–3.
10.
Gilling PJ, Cass CB, Cresswell MD, Malcolm AR, Fraundorfer MR. The use of the holmium laser in the treatment of benign prostatic hyperplasia.
J Endourol
. 1996 Oct; 10(5): 459–61.
11.
Gravas S, Bach T, Drake M, et al.
EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO)
. EAU; 2017.
12.
Kim M, Lee HE, Oh SJ. Technical aspects of holmium laser enucleation of the prostate for benign prostatic hyperplasia.
Korean J Urol
. 2013 Sep; 54(9): 570–9.
13.
Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years.
BJU Int
. 2012 Feb; 109(3): 408–11.
14.
Sun N, Fu Y, Tian T, Gao J, Wang Y, Wang S, et al. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a randomized clinical trial.
Int Urol Nephrol
. 2014 Jul; 46(7): 1277–82.
15.
Yin L, Teng J, Huang CJ, et al. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systemic review and meta-analysis of randomized controlled trials. J Endourol 2013; 27: 604–11.
16.
Ahyai SA, Chun FK, Lehrich Ket al. Transurethral resection of the prostate and simple open prostatectomy which procedure is faster? J Urol 2012 ; 187: 1608–13.
17.
Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial.
Eur Urol
. 2008 Jan; 53(1): 160–6.
18.
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates [{GT}]70 g: 24-month follow-up.
Eur Urol
. 2006 Sep; 50(3): 563–8.
19.
Glybochko PV, Rapoport LM, Enikeev ME, Enikeev DV. Holmium laser enucleation of the prostate (HoLEP) for small, large and giant prostatic hyperplasia: tips and tricks.
Urologia
. 2017 Aug; 84(3): 169–73.
20.
Salonia A, Suardi N, Naspro R, Mazzoccoli B, Zanni G, Gallina A, et al. Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis.
Urology
. 2006 Aug; 68(2): 302–6.
21.
Kuntz RM, Lehrich K. Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: a randomized prospective trial of 120 patients.
J Urol
. 2002 Oct; 168(4 Pt 1): 1465–9.
22.
Becker B, Netsch C, Glybochko P, Rapoport L, Taratkin M, Enikeev D. A Feasibility Study Utilizing the Thulium and Holmium Laser in Patients for the Treatment of Recurrent Benign Prostatic Hyperplasia after Previous Prostatic Surgery.
Urol Int
. 2018; 101(2): 212–8.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.